A B C Z INF AP 

C01

Optimization and evaluation of cmyc – directed liver cancer therapy

C02

Combinatorial targeting of epigenetic mechanisms in liver cancer

C03

HCC and the hepatic vascular niche: Analysis of angiocrine and adhesive vascular targets

C05

Microsphere-based immunotherapy of HCC

C06

Targeting the mutanome of liver cancer by viral oncolysis and tumor-directed immunotherapies

C07

Identification of molecular mechanisms conferring resistance to oncolytic viruses in HCC and implications for successful HCC virotherapy